CA$
0. 03
0
0%
CA$
16.48M Market Cap
- P/E Ratio
- Div Yield
44,000 Volume
0 Eps
CA$ 0.03
Previous Close Want to track KNE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kane Biotech Inc. (KNE) Statistics
Valuation metrics
Market Cap 16.48M
Enterprise value 7.26M
Trailing P/E (ttm) -2.05
Forward P/E -
PEG ratio 0.07
Price/Sales (ttm) 158.88
Price/Book (mrq) -6.19
Enterprise Value/Revenue 187.51
Enterprise Value/EBITDA -2.36
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.36K
Average volume (90 days) 84.97K
Price summary
52-Week low 0.02
52-Week high 0.05
Beta -
50-Day moving average 0.03
200-Day moving average 0.03
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 13 Mar 2017
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -69.8%
Operating margin -81.14%
Operational effectiveness
Return on assets -1.21%
Return on equity 2.74%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.01
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) -1.98
Current ratio (mrq) 0.61%
Book value per share (mrq) -0
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
